2 unknown, 2 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Withdrawn 2 |
Follow InSight: new trials by email Literature Review of InSight trials Research Report on InSight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gram Type Infection-Specific Sepsis Identification Using Machine Learning InSight - Sepsis, Severe Sepsis | Phase 2 | Withdrawn | Dascena | 2022-05-01 | 2021-09-23 | |
| Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment Treatment-specific InSight, InSight - Sepsis, Severe Sepsis | Phase 2 | Unknown | Dascena | 51645 | 2022-04-01 | 2021-09-23 |
| Machine Learning Sepsis Alert Notification Using Clinical Data HindSight, InSight - Sepsis, Severe Sepsis | Phase 2 | Unknown | Dascena | 37986 | 2021-09-25 | 2022-05-03 |
| RCT of Sepsis Machine Learning Algorithm InSight - Sepsis, Severe Sepsis | Phase 2 | Withdrawn | Dascena | 2020-01-01 | 2021-09-23 |
Sepsis (4) · Shock, Septic (4) · Disease (3)
Dascena (4)
United States (1)
Ritankar Das, MSc (2) · Jana Hoffman, PhD (1) · Qingqing Mao, PhD (1)
R44AA030000 (1)